EH
Therapeutic Areas
Zura Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Tibulizumab (ZB-106) | Systemic Sclerosis (SSc) | Phase 2 |
| Crebankitug (ZB-168) | Not Disclosed (IL-7/TSLP-driven diseases) | Preclinical/Phase 1 |
| Torudokimab (ZB-880) | Not Disclosed (ST2/RAGE-mediated inflammation) | Preclinical/Phase 1 |